Logotype for Waystar Holding Corp

Waystar (WAY) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Waystar Holding Corp

Q2 2026 earnings summary

29 Jul, 2026

Executive summary

  • Q2 2026 revenue reached $320 million, up 18% year-over-year, with adjusted EBITDA of $137 million and a 43% margin, and net income of $40.9 million, exceeding consensus expectations.

  • Strong client growth with 1,453 clients generating over $100,000 in trailing 12-month revenue, up 15% year-over-year, driven by large provider organizations and demand for AI-powered solutions.

  • Over 99% of revenue is recurring, supported by robust subscription and volume-based fees, with net revenue retention at 108%.

  • Platform consolidation and AI-powered solutions are accelerating, with providers seeking integrated offerings and significant ROI.

  • Announced CFO transition: Steve Oreskovich to advisor role, Alpana Wegner appointed as new CFO.

Financial highlights

  • Q2 2026 revenue was $319.7 million, up 18.1% year-over-year, with adjusted EBITDA of $136.7 million and a 43% margin.

  • Subscription revenue reached $176.3 million (34% year-over-year growth), 55% of total revenue; volume-based revenue was $142.1 million, up 3%.

  • Net income for Q2 2026 was $40.9 million, with diluted EPS of $0.21.

  • Unlevered free cash flow for Q2 was $63.9 million, with a 57% conversion rate from adjusted EBITDA.

  • Ended quarter with $12.6 million in cash, $179 million in investment securities, and $1.47 billion in total debt.

Outlook and guidance

  • Full-year 2026 revenue guidance raised to $1.276–$1.294 billion (midpoint $1.285 billion, 17% year-over-year growth).

  • Adjusted EBITDA guidance increased to $535–$545 million (midpoint $540 million), with margin guidance at 42%.

  • Non-GAAP net income forecasted at $322–$340 million, with diluted non-GAAP EPS of $1.61–$1.70.

  • Continued investment in AI and automation, balancing margin expansion with growth initiatives.

  • Seasonality expected in Q4 due to patient deductible dynamics; visibility into 2027 revenue from large deals and cross-sell opportunities.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more